Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease
Indexado
WoS WOS:000511435900014
Scopus SCOPUS_ID:85077692764
DOI 10.1007/S00204-019-02630-3
Año 2020
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Inflammation has been recognized as essential for restorative regeneration. Here, we analyzed the sequential processes during onset of liver injury and subsequent regeneration based on time-resolved transcriptional regulatory networks (TRNs) to understand the relationship between inflammation, mature organ function, and regeneration. Genome-wide expression and TRN analysis were performed time dependently in mouse liver after acute injury by CCl4 (2 h, 8 h, 1, 2, 4, 6, 8, 16 days), as well as lipopolysaccharide (LPS, 24 h) and compared to publicly available data after tunicamycin exposure (mouse, 6 h), hepatocellular carcinoma (HCC, mouse), and human chronic liver disease (non-alcoholic fatty liver, HBV infection and HCC). Spatiotemporal investigation differentiated lobular zones for signaling and transcription factor expression. Acute CCl4 intoxication induced expression of gene clusters enriched for inflammation and stress signaling that peaked between 2 and 24 h, accompanied by a decrease of mature liver functions, particularly metabolic genes. Metabolism decreased not only in pericentral hepatocytes that underwent CCl4-induced necrosis, but extended to the surviving periportal hepatocytes. Proliferation and tissue restorative TRNs occurred only later reaching a maximum at 48 h. The same upstream regulators (e.g. inhibited RXR function) were implicated in increased inflammation and suppressed metabolism. The concomitant inflammation/metabolism TRN occurred similarly after acute LPS and tunicamycin challenges, in chronic mouse models and also in human liver diseases. Downregulation of metabolic genes occurs concomitantly to induce inflammation-associated genes as an early response and appears to be initiated by similar upstream regulators in acute and chronic liver diseases in humans and mice. In the acute setting, proliferation and restorative regeneration associated TRNs peak only later when metabolism is already suppressed.

Revista



Revista ISSN
Archives Of Toxicology 0340-5761

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Toxicology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Campos, Gisela Mujer Tech Univ Dortmund - Alemania
TU Dortmund University - Alemania
Technische Universität Dortmund - Alemania
2 Schmidt-Heck, Wolfgang Hombre Nat Product Res & Infect Biol eV - Alemania
Hans-Knoll-Institute (HKI) - Alemania
Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. – Hans-Knöll-Institut - Alemania
3 De Smedt, Jonathan Hombre Katholieke Univ Leuven - Bélgica
KU Leuven - Bélgica
4 Widera, Agata Mujer Tech Univ Dortmund - Alemania
TU Dortmund University - Alemania
Technische Universität Dortmund - Alemania
5 Ghallab, Ahmed Hombre South Valley Univ - Egipto
TU Dortmund University - Alemania
South Valley University - Egipto
Technische Universität Dortmund - Alemania
Faculty of Veterinary Medicine - Egipto
6 Pütter, Larissa Mujer TU Dortmund University - Alemania
Technische Universität Dortmund - Alemania
6 Puetter, Larissa Mujer Tech Univ Dortmund - Alemania
7 GONZALEZ-LEIVA, DANIELA Mujer Tech Univ Dortmund - Alemania
TU Dortmund University - Alemania
Technische Universität Dortmund - Alemania
8 Edlund, Karolina Mujer Tech Univ Dortmund - Alemania
TU Dortmund University - Alemania
Technische Universität Dortmund - Alemania
9 Cadenas, Cristina Mujer Tech Univ Dortmund - Alemania
TU Dortmund University - Alemania
Technische Universität Dortmund - Alemania
10 Marchan, Rosemarie Mujer Tech Univ Dortmund - Alemania
TU Dortmund University - Alemania
Technische Universität Dortmund - Alemania
11 Guthke, Reinhard Hombre Nat Product Res & Infect Biol eV - Alemania
Hans-Knoll-Institute (HKI) - Alemania
Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. – Hans-Knöll-Institut - Alemania
12 Verfaillie, Catherine Mujer Katholieke Univ Leuven - Bélgica
KU Leuven - Bélgica
13 HETZ-FLORES, CLAUDIO ANDRES Hombre Universidad de Chile - Chile
Centro de Gerociencia, Salud Mental y Metabolismo - Chile
Buck Inst Res Aging - Estados Unidos
Harvard Sch Publ Hlth - Estados Unidos
Buck Institute for Age Research - Estados Unidos
Harvard T.H. Chan School of Public Health - Estados Unidos
Buck Institute for Research on Aging - Estados Unidos
14 Sachinidis, Agapios Hombre Univ Cologne - Alemania
University of Cologne - Alemania
Universität zu Köln - Alemania
15 Braeuning, Albert Hombre UNIV TUBINGEN - Alemania
Fed Inst Risk Assessment - Alemania
Universität Tübingen - Alemania
Bundesinstitut für Risikobewertung - Alemania
Eberhard Karls Universität Tübingen - Alemania
16 Schwarz, Michael Hombre UNIV TUBINGEN - Alemania
Universität Tübingen - Alemania
Eberhard Karls Universität Tübingen - Alemania
17 Weiss, Thomas S. Hombre Univ Regensburg Hosp - Alemania
Universität Regensburg - Alemania
18 Banhart, Benjamin K. Hombre Thomas Jefferson Univ - Estados Unidos
Thomas Jefferson University - Estados Unidos
19 Hoek, Jan - Thomas Jefferson Univ - Estados Unidos
Thomas Jefferson University - Estados Unidos
20 Vadigepalli, Rajanikanth - Thomas Jefferson Univ - Estados Unidos
Thomas Jefferson University - Estados Unidos
21 Willy, Jeffrey Hombre Vertex Pharmaceut - Estados Unidos
Vertex Pharmaceuticals, Inc. - Estados Unidos
22 Stevens, James L. Hombre ELI LILLY & CO - Estados Unidos
Eli Lilly and Company - Estados Unidos
23 Hay, David C. Hombre UNIV EDINBURGH - Reino Unido
University of Edinburgh, MRC Centre for Regenerative Medicine - Reino Unido
24 Hengstler, Jan G. Hombre Tech Univ Dortmund - Alemania
TU Dortmund University - Alemania
Technische Universität Dortmund - Alemania
25 GODOY-MARTINEZ, PATRICIO CHRISTIAN Hombre Tech Univ Dortmund - Alemania
TU Dortmund University - Alemania
Technische Universität Dortmund - Alemania

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
FONDECYT
Fondo Nacional de Desarrollo Científico y Tecnológico
Millennium Institute
German Federal Ministry of Education and Research
Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica
Seventh Framework Programme
Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias
European Union’s Horizon 2020
Bundesministerium für Bildung und Forschung
Horizon 2020 Framework Programme
FP7 Health
Nottingham City Primary Care Trust (GB)
Helmholtz Virtuelles Institut Multifunktionale Biomaterialien fur die Medizin (DE)
BMBF/EU
Senate Commission on Food Safety
DFG WISP
InnoSysTox
EU-project FP7-Health
EU-ToxRisk
Leibniz Research Centre for Working Environment and Human Factors, Technical University of Dortmund

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
We thank Ms. Katharina Rochlitz, Ms. Brigitte Begher-Tibbe, and Ms. Georgia Günther (Leibniz Research Centre for Working Environment and Human Factors, Technical University of Dortmund, Germany) for excellent technical assistance. This work has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 681002 (EU-ToxRisk), from TransQST (No. 116030), LivSysTransfer (BMBF, 031L0119) with contributions from StemCellNet (BMBF, 01EK1604A), LiSyM (BMBF, 031Loo45), and InnoSysTox (BMBF/EU, 031L0021A) We thank the Permanent Senate Commission on Food Safety (SKLM) for valuable discussion.

Muestra la fuente de financiamiento declarada en la publicación.